Robeco Institutional Asset Management B.V. Decreases Stake in Church & Dwight Co., Inc. (NYSE:CHD)

Robeco Institutional Asset Management B.V. reduced its position in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,043,508 shares of the company's stock after selling 13,090 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.42% of Church & Dwight worth $114,880,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CHD. Norges Bank acquired a new position in Church & Dwight in the 4th quarter valued at $318,532,000. JPMorgan Chase & Co. increased its stake in shares of Church & Dwight by 19.4% in the 4th quarter. JPMorgan Chase & Co. now owns 7,336,046 shares of the company's stock worth $768,157,000 after acquiring an additional 1,190,154 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Church & Dwight by 12,489.8% in the 1st quarter. GAMMA Investing LLC now owns 861,895 shares of the company's stock worth $94,886,000 after acquiring an additional 855,049 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Church & Dwight in the 4th quarter worth $76,565,000. Finally, Ceredex Value Advisors LLC acquired a new stake in shares of Church & Dwight in the 4th quarter worth $49,504,000. 86.60% of the stock is owned by institutional investors and hedge funds.

Church & Dwight Trading Down 0.1%

Shares of NYSE:CHD traded down $0.13 during midday trading on Friday, reaching $94.84. 3,093,647 shares of the company's stock were exchanged, compared to its average volume of 1,766,081. The firm's 50 day simple moving average is $97.06 and its two-hundred day simple moving average is $103.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.95 and a quick ratio of 1.43. The stock has a market cap of $23.36 billion, a price-to-earnings ratio of 40.71, a P/E/G ratio of 3.81 and a beta of 0.52. Church & Dwight Co., Inc. has a fifty-two week low of $90.99 and a fifty-two week high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.02. Church & Dwight had a return on equity of 19.28% and a net margin of 9.52%. The company had revenue of $1.47 billion during the quarter, compared to analysts' expectations of $1.52 billion. During the same period last year, the business posted $0.96 EPS. Church & Dwight's revenue for the quarter was down 2.4% on a year-over-year basis. As a group, sell-side analysts forecast that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Thursday, May 15th were issued a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date was Thursday, May 15th. Church & Dwight's dividend payout ratio (DPR) is 50.64%.

Analysts Set New Price Targets

CHD has been the subject of a number of recent research reports. TD Cowen downgraded Church & Dwight from a "buy" rating to a "hold" rating and set a $100.00 target price for the company. in a research note on Tuesday, May 6th. Evercore ISI cut their target price on Church & Dwight from $106.00 to $102.00 and set an "in-line" rating for the company in a research note on Friday, May 2nd. Morgan Stanley cut their target price on Church & Dwight from $110.00 to $100.00 and set an "equal weight" rating for the company in a research note on Monday, May 5th. Bank of America raised Church & Dwight from a "neutral" rating to a "buy" rating and raised their target price for the stock from $112.00 to $125.00 in a research note on Tuesday, April 15th. Finally, Barclays cut their target price on Church & Dwight from $94.00 to $84.00 and set an "underweight" rating for the company in a research note on Friday, May 2nd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Church & Dwight presently has a consensus rating of "Hold" and an average target price of $108.29.

Insider Activity at Church & Dwight

In other news, EVP Michael Read bought 3,000 shares of the stock in a transaction that occurred on Friday, May 9th. The stock was bought at an average cost of $92.07 per share, for a total transaction of $276,210.00. Following the acquisition, the executive vice president now directly owns 5,505 shares of the company's stock, valued at $506,845.35. The trade was a 119.76% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Ravichandra Krishnamu Saligram sold 14,660 shares of the firm's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $99.00, for a total value of $1,451,340.00. Following the transaction, the director now owns 13,747 shares of the company's stock, valued at $1,360,953. This trade represents a 51.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,575 shares of company stock worth $4,910,586 in the last three months. 2.00% of the stock is owned by company insiders.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.